Targeting death receptors in cancer with Apo2L/TRAILSean K. Kelley(Genesys (United States))Current Opinion in PharmacologyJune 8, 200410.1016/j.coph.2004.02.006Cited by 370SaveCiteExport RISWatch citationsAbstractRelated PapersNo related papers foundPowered by citation graph analysis